Related Experiment Video
Updated: Jul 16, 2026
06:28
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
Cytokine gene polymorphisms in acquired bone marrow failure.
Vinod Gidvani1, Shakti Ramkissoon, Elaine M Sloand
1Pediatric Hematology Oncology, Wilford Hall Medical Center, Lackland Air Force Base, Texas, USA.
American Journal of Hematology
|March 22, 2007
Summary
Certain acquired aplastic anemia (AA) cases involve immune destruction of stem cells. Gene variations in cytokines like TNF-alpha and IFN-gamma may increase susceptibility to AA by promoting inflammation.
Area of Science:
- Immunology
- Genetics
- Hematology
Background:
- Acquired aplastic anemia (AA) is often immune-mediated, targeting hematopoietic stem cells.
- Cytokine gene polymorphisms influence cytokine production and autoimmune disease risk.
Purpose of the Study:
- To investigate the association between specific cytokine gene polymorphisms and acquired aplastic anemia.
- To determine if these polymorphisms correlate with altered cytokine production in AA patients.
Main Methods:
- Genotyping of single nucleotide polymorphisms (SNPs) in IL-6, TNF-alpha, IL-10, IFN-gamma, TGFbeta1, and IL1-RA VNTR alleles in 73 AA patients.
- Comparison of genotype frequencies with control populations.
Main Results:
- Some patients with acquired AA exhibit polymorphisms linked to high production of pro-inflammatory cytokines.
- Specifically, polymorphisms associated with elevated TNF-alpha and IFN-gamma were observed.
Conclusions:
- Cytokine gene polymorphisms may play a role in the pathogenesis of acquired aplastic anemia.
- Elevated pro-inflammatory cytokine production, particularly TNF-alpha and IFN-gamma, could be a contributing factor in some AA cases.
More Related Videos
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...